FDA approves Medtronic's CoreValve for transcatheter VIV procedures
The FDA has approved, for the first time, a transcathter heart valve for valve-in-valve (VIV) procedures in patients whose surgical aortic heart valves have failed. The agency expanded the approved use of Medtronic's (Dublin, Ireland) CoreValve system for VIV procedures in patients in need of a second valve replacement who are at high or extreme risk for complications associated with traditional open-heart surgery.
From time to time, it's nice to rediscover I'm not the only cynic in the room. So I was obviously relieved to see a couple of criticisms of the latest orthodoxy about the future practice of medicine. The question is: Is the Precision Medicine Initiative the real deal or just another government gamble on the ponies?
Google faces potential challenges, roadblocks in getting Glass adopted
When Jay Zuerndorfer, a student researcher at the Georgia Institute of Technology (Atlanta) received the opportunity to develop an application for Google Glass it was like a dream come true. Zuerndorfer and a research team from Georgia Tech were able to create speech-to-text software for Google Glass that helps hard-of-hearing users with everyday conversations. A hard-of-hearing person wears Glass while a second person speaks directly into a smart phone.